AGP Picks
View all

Financial Markets Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Financial Markets Network.

Press releases published on November 11, 2026

More than half of Filipinos will be middle class or better off by 2031
Staera Semiconductor emerges from stealth with US$4.6 million to break AI's data bottleneck
CMCT Investor Losses: KT Files $200K FINRA Claim Against Cambridge Investment Research
Malaysia's Sultan Nazrin Shah Address to Silver Economy Forum 2026: ASEAN Can Build for Longevity from the Ground Up
SmiKar Launches Forage for Squirrel, Bringing Archived SharePoint Content Back into Search, AI and Microsoft Copilot
ZIGRAM Joins FinTech Alliance.PH to Strengthen Financial Crime Prevention
Worldbox Business Intelligence Achieves ISO 27001
Vanna Health Announces Key Executive Appointments Following Series B Funding Round
Agreement signed at COP31 to launch new Platform for Agricultural Carbon in Africa
DELÅRSRAPPORT 3. KVT. 2026 - FORTSAT PÅ RET KURS. FORTSAT MERE AT GØRE
Q3 2026 INTERIM REPORT - STILL ON TRACK. STILL MORE TO DO
Airwheel Showcases Smart Ai Wheel Rideable Hand 20 inch Carry On Airport Boarding Cabin Luxury Suitcase Opens a New Chapter for Modern Travel Luggage
Gleim Exam Prep Names Amy Ford, CPA, CMA, FMAA, as Professor in Residence
Onco-Innovations Announces Agreement to Terminate Performance-Based Funding Arrangement with Sorbie
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Prime Medicine Announces Pricing of Public Offering of Common Stock
Wanlian Securities begleitet „Guangzhous ersten Chip“ beim Börsengang am ChiNext-Markt – langfristig orientiertes Kapital stärkt Chinas Hard-Tech-Industrie
Wanlian Securities Dá Suporte ao "Primeiro Chip de Guangzhou" na Sua Listagem na ChiNext. Capital Paciente Impulsiona Desenvolvimento do Setor de Hard Tech da China
AGCバイオロジクス、チャイルズ・キュア・ジネティック・リサーチと提携し、重度のてんかん性疾患に対するmRNAベースの治療薬の開発に取り組む
AGC 바이오로직스, 차일즈 큐어 유전연구재단과 협력해 중증 뇌전증 질환 치료 위한 mRNA 기반 치료제 개발 추진

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Financial Markets Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.